MarketInOut Stock Screener Log In | Sign Up

Cytosorbents Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026
Cytosorbents Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization14.31 mln
Float2.71 mln
Earnings Date10/29/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.88
Highly reliable

Relative Strength

92 / 100
Top performer

Pre-Tax Margin

-50%
Deeply loss-making

ROE

-326
Deeply negative

Altman Z-Score

-12.27
Deeply distressed

Business Description

Founded in 1997 and based in Princeton, New Jersey, Cytosorbents Corporation develops and sells medical devices built around a specialized polymer technology that filters harmful substances from the blood. Its best-known product, CytoSorb, is used in hospital settings to treat serious conditions such as sepsis, organ failure, and complications arising from heart surgery. The company also offers a range of related products targeting drug removal, veterinary care, organ preservation, and blood compatibility, serving customers across the United States, Germany, and other international markets.

Key Fundamentals

EPS-5.80
ROE-326
RPS11.86
ROIC-31.76
ROA-41.41
Interest Cover-8.86
EBITDA, mln-13.96
EV / EBITDA-2.86
EV / EBIT-2.57
Revenue, mln37.22
EV / Revenue1.07

Quote Details

Last 4.54
Change 0.14 (3.18%)
Open 4.39
Volume 24,101
Turnover 109,419
Average Volume 67,486

Financial Ratios

Pre-Tax Profit Margin-50
Current Ratio0.66
Price / Sales0.38

Financial Strength

Altman Z-Score-12.27
Piotroski F-Score 5 / 9
Beneish M-Score-3.88
Short Ratio10.48
Short % of Float3.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -13.85% 7 / 100   
1 Month 8.61% 90 / 100   
2 Months -36.94% 13 / 100   
6 Months -63.06% 9 / 100   
1 Year -70.97% 12 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog